Abstract

The tannase-producing Gram-positive bacterial species Streptococcus gallolyticus subsp. gallolyticus (Sgg) is an opportunistic pathogen of the human gut and strongly associated with colorectal cancer (CRC). A unique feature of Sgg is its ability to degrade tannic acids (TA). TA constitute an important part of the human diet with known anti-tumorigenic properties. Here, we examined whether Sgg is able to protect tumor cells from the toxic effect of TA and thus drive tumorigenesis indirectly. Human CRC cell lines (n = 8) were treated with increasing concentrations of TA. We confirmed the cytotoxic activity of TA in a dose-dependent manner. In virtually all cell lines, viability decreased significantly (>60% inhibition). Moreover, pyrogallol, the degradation product of TA, had no effect on the tested cell lines. This suggests a specific effect of TA. Cytotoxicity was due to necrosis and induction of senescence in residual cells. Finally, when TA was degraded by Sgg, the cytotoxic effect could be abolished. Tumor cells even responded with boosted cell proliferation, highlighting the impact of Sgg on CRC progression. We here provide another piece of evidence for the active interplay between Sgg and cancer preventive components. These data will help to move forward in designing concepts for therapeutic and eventually also prophylactic approaches to combat gastrointestinal malignancies.

Details

Title
Streptococcus gallolyticus abrogates anti-carcinogenic properties of tannic acid on low-passage colorectal carcinomas
Author
Oehmcke-Hecht Sonja 1 ; Mandl, Vanessa 2 ; Naatz Lukas Tim 2 ; Dühring Lara 2 ; Köhler Juliane 1 ; Kreikemeyer Bernd 1 ; Maletzki Claudia 3 

 Virology and Hygiene, Rostock University Medical Center, Institute of Medical Microbiology, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454) 
 Virology and Hygiene, Rostock University Medical Center, Institute of Medical Microbiology, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454); Medical Clinic III - Hematology, Oncology, Palliative Care, Rostock University Medical Center, Department of Internal Medicine, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454) 
 Medical Clinic III - Hematology, Oncology, Palliative Care, Rostock University Medical Center, Department of Internal Medicine, Rostock, Germany (GRID:grid.413108.f) (ISNI:0000 0000 9737 0454) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2376946437
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.